Anti-atherosclerotic action of GW9508 - Free fatty acid receptors activator - In apoE-knockout mice
- PMID: 31129318
- DOI: 10.1016/j.pharep.2019.02.014
Anti-atherosclerotic action of GW9508 - Free fatty acid receptors activator - In apoE-knockout mice
Abstract
Background: In the past two decades, enhanced understanding of the biology of G-protein-coupled receptors (GPRs) has led to the identification of several such receptors as novel targets for free fatty acids (FFAs). Two GPRs, FFAR1 and FFAR4, have received special attention in the context of chronic inflammatory diseases, thanks to their anti-inflammatory activities.
Methods: The present study investigates the influence of prolonged treatment with GW9508 - agonist of FFAR1 and FFAR4 - on the development of atherosclerosis plaque in apoE-knockout mice, using morphometric and molecular methods.
Results: GW9508 administration has led to the reduction of atheroscletoric plaque size in an apoE-knockout mice model. Moreover, a FFAR1/FFAR4 agonist reduced the content of macrophages by almost 20%, attributed by immunohistochemical phenotyping to the pro-inflammatory M1-like activation state macrophages.
Conclusions: Prolonged administration of GW9508 resulted in significant amelioration of atherogenesis, providing evidence that the strategy based on macrophage phenotype switching toward an M2-like activation state via stimulation of FFAR1/FFAR4 receptors holds promise for a new approach to the prevention or treatment of atherosclerosis.
Keywords: Atherosclerosis; Free fatty acid receptors; GW9508; Macrophages; apoE-knockout mice.
Copyright © 2019 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.
Similar articles
-
The Anti-Atherosclerotic Action of FFAR4 Agonist TUG-891 in ApoE-Knockout Mice Is Associated with Increased Macrophage Polarization towards M2 Phenotype.Int J Mol Sci. 2021 Sep 9;22(18):9772. doi: 10.3390/ijms22189772. Int J Mol Sci. 2021. PMID: 34575934 Free PMC article.
-
Anti-Atherosclerotic Potential of Free Fatty Acid Receptor 4 (FFAR4).Biomedicines. 2021 Apr 24;9(5):467. doi: 10.3390/biomedicines9050467. Biomedicines. 2021. PMID: 33923318 Free PMC article. Review.
-
Activation of free fatty acid receptors, FFAR1 and FFAR4, ameliorates ulcerative colitis by promote fatty acid metabolism and mediate macrophage polarization.Int Immunopharmacol. 2024 Mar 30;130:111778. doi: 10.1016/j.intimp.2024.111778. Epub 2024 Mar 2. Int Immunopharmacol. 2024. PMID: 38432147
-
Novel identification of the free fatty acid receptor FFAR1 that promotes contraction in airway smooth muscle.Am J Physiol Lung Cell Mol Physiol. 2015 Nov 1;309(9):L970-82. doi: 10.1152/ajplung.00041.2015. Epub 2015 Sep 4. Am J Physiol Lung Cell Mol Physiol. 2015. PMID: 26342087 Free PMC article.
-
FFAR4: A New Player in Cardiometabolic Disease?Endocrinology. 2021 Aug 1;162(8):bqab111. doi: 10.1210/endocr/bqab111. Endocrinology. 2021. PMID: 34043793 Free PMC article. Review.
Cited by
-
The Influence of the FFAR4 Agonist TUG-891 on Liver Steatosis in ApoE-Knockout Mice.Cardiovasc Drugs Ther. 2024 Aug;38(4):667-678. doi: 10.1007/s10557-023-07430-7. Epub 2023 Jan 27. Cardiovasc Drugs Ther. 2024. PMID: 36705799 Free PMC article.
-
The Anti-Atherosclerotic Action of FFAR4 Agonist TUG-891 in ApoE-Knockout Mice Is Associated with Increased Macrophage Polarization towards M2 Phenotype.Int J Mol Sci. 2021 Sep 9;22(18):9772. doi: 10.3390/ijms22189772. Int J Mol Sci. 2021. PMID: 34575934 Free PMC article.
-
Anti-Atherosclerotic Potential of Free Fatty Acid Receptor 4 (FFAR4).Biomedicines. 2021 Apr 24;9(5):467. doi: 10.3390/biomedicines9050467. Biomedicines. 2021. PMID: 33923318 Free PMC article. Review.
-
Agonism of Gpr40 Protects the Capacities of Epidermal Stem Cells (ESCs) Against Ultraviolet-B (UV-B).Drug Des Devel Ther. 2020 Nov 24;14:5143-5153. doi: 10.2147/DDDT.S252060. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 33262575 Free PMC article.
-
GPR40/GPR120 Agonist GW9508 Improves Metabolic Syndrome-Exacerbated Periodontitis in Mice.Int J Mol Sci. 2024 Sep 5;25(17):9622. doi: 10.3390/ijms25179622. Int J Mol Sci. 2024. PMID: 39273569 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous